Edition:
United States

Zoetis Inc (ZTS.N)

ZTS.N on New York Stock Exchange

54.19USD
21 Apr 2017
Change (% chg)

$-0.10 (-0.18%)
Prev Close
$54.29
Open
$54.23
Day's High
$54.38
Day's Low
$54.00
Volume
693,006
Avg. Vol
867,410
52-wk High
$56.50
52-wk Low
$45.28

Latest Key Developments (Source: Significant Developments)

Zoetis to acquire Nexvet for US$6.72 in Cash Per Share
Thursday, 13 Apr 2017 09:24am EDT 

Zoetis Inc : Zoetis to acquire Nexvet Biopharma, an innovator in monoclonal antibody therapies for companion animals . Deal for purchase price of US$6.72 per share . Deal for approximately US$85 million in aggregate . Board of directors of Nexvet has unanimously approved acquisition . Under terms of proposed acquisition, Nexvet shareholders will receive us$6.72 in cash per ordinary share .Cash consideration payable by Zoetis under terms of proposed acquisition will be funded by cash on hand.  Full Article

Zoetis reports Q4 EPS $0.31
Thursday, 16 Feb 2017 07:00am EST 

Zoetis Inc : Updates full year 2017 revenue guidance . Zoetis reports fourth quarter and full year 2016 results . Q4 adjusted earnings per share $0.47 . Q4 earnings per share $0.31 . Q4 revenue $1.3 billion versus I/B/E/S view $1.27 billion . Q4 earnings per share view $0.45 -- Thomson Reuters I/B/E/S . Sees fy 2017 adjusted earnings per share $2.26 to $2.36 . Sees fy 2017 earnings per share $2.08 to $2.20 . Sees fy 2017 revenue $5.1 billion to $5.225 billion . Zoetis Inc - "Cash flow is expected to grow significantly in 2017" .Fy2017 earnings per share view $2.33, revenue view $5.18 billion -- Thomson Reuters I/B/E/S.  Full Article

Zoetis says entered into a revolving credit agreement with a syndicate of banks
Wednesday, 21 Dec 2016 04:10pm EST 

Zoetis Inc : Zoetis -company will have the right to increase the commitments under the credit agreement to up to $1.5 billion . Zoetis Inc - on December 21, 2016, Zoetis Inc entered into a revolving credit agreement with a syndicate of banks - sec filing .Zoetis Inc- revolving credit agreement providing for a five-year $1.0 billion senior unsecured revolving credit facility.  Full Article

Zoetis announces authorization of $1.5 bln share repurchase program
Tuesday, 6 Dec 2016 04:15pm EST 

Zoetis Inc : Zoetis inc says board of directors also declared a q1 2017 dividend of $0.105 per share, an increase of 10.5% . Company's previous $500 million share repurchase program, which was approved in november 2014, is expected to be completed at end of this year .Zoetis announces authorization of $1.5 billion share repurchase program.  Full Article

Valeant appoints Paul Herendeen as chief financial officer
Monday, 22 Aug 2016 06:00am EDT 

Valeant Pharmaceuticals International Inc : Valeant pharmaceuticals appoints Paul S. Herendeen as executive vice president, finance and chief financial officer . Herendeen will take over role of chief financial officer from Robert L. Rosiello effective immediately . Prior to joining Valeant, Herendeen served as executive vice president and chief financial officer of Zoetis Inc. For two years .Rosiello will assume responsibility for corporate development and strategy and continues as evp and an executive committee member.  Full Article

Zoetis appoints Glenn David as CFO
Sunday, 21 Aug 2016 09:13pm EDT 

Zoetis Inc : Zoetis announces appointment of Glenn David as executive vice president and chief financial officer . Glenn David, senior vice president of finance operations, has been named executive vice president and chief financial officer .Glenn david will succeed CFO paul herendeen, who has resigned effective august 18, 2016, to accept position of CFO at another public co.  Full Article

Pershing Square Capital Management cuts share stake in Zoetis by 49 pct
Monday, 15 Aug 2016 06:00pm EDT 

Zoetis Inc :Pershing Square Capital Management cuts share stake in Zoetis by 49 percent to 21.1 million shares - SEC filing.  Full Article

Zoetis acquires Scandinavian Micro Biodevices to extend pipeline in veterinary diagnostics
Monday, 8 Aug 2016 08:00am EDT 

Zoetis Inc : Deal for $80 million . Zoetis acquires scandinavian micro biodevices to extend its pipeline in diagnostics for veterinary use .Deal for $80 million.  Full Article

Zoetis reports Q2 earnings per share $0.45
Wednesday, 3 Aug 2016 07:00am EDT 

Zoetis Inc : Q2 adjusted earnings per share $0.49 . Sees fy 2016 adjusted earnings per share $1.86 to $1.93 . Q2 earnings per share $0.45 . Q2 earnings per share view $0.44 -- Thomson Reuters I/B/E/S . Zoetis reports second quarter 2016 results . Q2 revenue $1.2 billion versus I/B/E/S view $1.17 billion . Sees fy 2016 earnings per share $1.52 to $1.63 . Sees fy 2016 revenue $4.8 billion to $4.9 billion . Sees reported diluted eps for full year 2016 between $1.52 to $1.63 per share .FY2016 earnings per share view $1.87, revenue view $4.85 billion -- Thomson Reuters I/B/E/S.  Full Article

William Ackman reports 3.8 pct stake in Zoetis Inc
Friday, 8 Jul 2016 05:08pm EDT 

Zoetis Inc :William Ackman reports 3.8 percent stake in Zoetis Inc as of July 7 versus 5.0 stake as of May 9 - SEC filing.  Full Article

More From Around the Web

BRIEF-Zoetis to acquire Nexvet for US$6.72 in Cash Per Share

* Zoetis to acquire Nexvet Biopharma, an innovator in monoclonal antibody therapies for companion animals